Treatment for Urethral Discharge
For adults with urethral discharge, initiate treatment with azithromycin 1 g orally as a single dose OR doxycycline 100 mg orally twice daily for 7 days after confirming urethritis through objective documentation. 1, 2, 3
Diagnostic Confirmation Required Before Treatment
Before initiating therapy, urethritis must be objectively documented using at least one of the following criteria:
- Mucopurulent or purulent discharge on examination 4
- Gram stain of urethral secretions showing ≥5 white blood cells per oil immersion field (≥2 WBCs per oil immersion field in women) 4, 1
- First-void urine microscopy demonstrating ≥10 white blood cells per high-power field 4
- Positive leukocyte esterase test on first-void urine 4
Critical caveat: Symptoms alone without objective evidence of urethral inflammation are insufficient for diagnosis or treatment initiation. 1 The absence of pyuria does not exclude sexually transmitted urethritis, as urethral swabs and first-catch urine have low sensitivity (29-62%) for detecting polymorphonuclear leukocytes in chlamydial and mycoplasma infections. 5
First-Line Treatment Regimens
Recommended options (choose one):
Doxycycline 100 mg orally twice daily for 7 days 4, 1, 2
- First-line for patients positive for both Mycoplasma genitalium and Ureaplasma 6
Both regimens are highly effective for chlamydial urethritis and have equivalent efficacy. 4, 1
Alternative Regimens
If first-line agents cannot be used:
- Erythromycin base 500 mg orally four times daily for 7 days 4, 6
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 4, 6
- Levofloxacin 500 mg orally once daily for 7 days 4, 6
- Ofloxacin 300 mg orally twice daily for 7 days 4, 6
When to Treat Empirically for Gonorrhea
If gonococcal infection is suspected or confirmed, add ceftriaxone:
- Ceftriaxone 500 mg IM as a single dose (for patients <150 kg) PLUS azithromycin 1 g orally 5, 7
- This dual therapy addresses both gonorrhea and likely chlamydial co-infection 8, 7
Empiric treatment for both gonorrhea and chlamydia is indicated for:
- Patients at high risk who are unlikely to return for follow-up (e.g., adolescents with multiple partners) 4
- Patients with severe urethritis or inability to follow up 5
Testing Strategy
All patients with confirmed or suspected urethritis should be tested for both N. gonorrhoeae and C. trachomatis before or at time of treatment. 4, 1
- Perform nucleic acid amplification testing (NAAT) on first-void urine or urethral swab 5
- Gram stain is the preferred rapid diagnostic test for documenting urethritis and identifying gonococcal infection (intracellular Gram-negative diplococci) 4, 5
- If NAAT is positive for gonorrhea, obtain culture for antimicrobial susceptibility testing 5
For mild symptoms with reliable follow-up: Consider delaying treatment until NAAT results guide pathogen-directed therapy. 5
Partner Management
All sexual partners within the preceding 60 days must be evaluated and treated with the same regimen as the index patient. 4, 1, 6
- Partners should be treated even if asymptomatic 1, 6
- Sexual abstinence is required for 7 days after treatment initiation and until symptoms resolve and partners are adequately treated 4, 1, 6
Follow-Up and Persistent Symptoms
Patients should return for evaluation only if symptoms persist or recur after completing therapy. 4, 1
- Routine post-treatment testing is not recommended in asymptomatic patients 1
- Symptoms alone without objective signs of urethritis are not sufficient for re-treatment 4
For persistent or recurrent urethritis:
- Re-treat with the initial regimen if non-compliant or re-exposed to untreated partner 4, 6
- If compliance was adequate and partner was treated, perform testing for Trichomonas vaginalis using NAAT or culture 1
- Consider treatment with metronidazole 2 g orally as a single dose PLUS azithromycin 1 g orally (if azithromycin was not used initially) 1
- For persistent cases, consider Mycoplasma genitalium with possible macrolide resistance, which may require moxifloxacin 400 mg daily for 7-14 days 5
Special Populations
Pregnant patients:
- Azithromycin 1 g orally as a single dose is the preferred treatment due to safety and effectiveness 1
- Doxycycline and fluoroquinolones are contraindicated in pregnancy 1
HIV-infected patients:
- Treat with the same regimens as HIV-negative patients 6
Critical Pitfalls to Avoid
- Do not defer treatment if objective signs of urethritis are present and patient is unlikely to return for follow-up 4
- Do not re-treat based on symptoms alone without documenting objective signs of urethritis 4
- Always test for syphilis in patients with sexually transmitted urethritis, as high-dose short-course antibiotics may mask incubating syphilis 3
- Ensure medication is provided directly in clinic when possible to improve compliance, especially for multi-dose regimens 4